Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-25-029344
Filing Date
2025-08-07
Accepted
2025-08-07 07:05:16
Documents
64
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 6-K ef20050525_6k.htm   iXBRL 6-K 50651
2 EXHIBIT 99.1 ef20050525_ex99-1.htm   iXBRL EX-99.1 688371
3 EXHIBIT 99.2 ef20050525_ex99-2.htm EX-99.2 239760
4 EXHIBIT 99.3 ef20050525_ex99-3.htm EX-99.3 164939
10 image00001.jpg GRAPHIC 3445
11 GRAPHIC image00002.jpg GRAPHIC 12028
  Complete submission text file 0001140361-25-029344.txt   4112168

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ghrs-20250630.xsd EX-101.SCH 43326
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ghrs-20250630_cal.xml EX-101.CAL 52533
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ghrs-20250630_def.xml EX-101.DEF 84407
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ghrs-20250630_lab.xml EX-101.LAB 430182
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ghrs-20250630_pre.xml EX-101.PRE 227207
67 EXTRACTED XBRL INSTANCE DOCUMENT ef20050525_6k_htm.xml XML 569222
Mailing Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95
Business Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95 353 1 437 8334
GH Research PLC (Filer) CIK: 0001855129 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40530 | Film No.: 251191532
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)